Invesco
CSBR icon

Invesco’s Champions Oncology CSBR Stock Holding History

Invesco’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,266
Closed -$224K – 3786
2020
Q3 		$224K Sell
24,266
-16,139
-40% -$144K ﹤0.01% 3424
2020
Q2 		$387K Buy
40,405
+2,345
+6% +$20K ﹤0.01% 3248
2020
Q1 		$281K Buy
38,060
+8,100
+27% +$56.6K ﹤0.01% 3288
2019
Q4 		$250K Sell
29,960
-8,330
-22% -$51.4K ﹤0.01% 3480
2019
Q3 		$217K Sell
38,290
-1,900
-5% -$12.3K ﹤0.01% 3526
2019
Q2 		$315K Sell
40,190
-10,250
-20% -$89.9K ﹤0.01% 3488
2019
Q1 		$493K Sell
50,440
-1,461
-3% -$14.6K ﹤0.01% 3318
2018
Q4 		$405K Buy
+51,901
New +$596K ﹤0.01% 3360

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco's CSBR Position: Q4 2020 in Review

Invesco sold out of Champions Oncology (CSBR) in Q4 2020, closing a stake of 24,266 shares — an estimated $224K sold.

Invesco first reported a position in CSBR in Q4 2018 and held it in 8 quarters. The position peaked at $493K in Q1 2019. 47 funds tracked by Wall St. Rank hold CSBR as of Q4 2020.

  • Invesco reported no remaining Champions Oncology position as of Q4 2020 after selling out during the quarter.
  • Invesco sold 24,266 Champions Oncology shares in Q4 2020, an estimated $224K.
  • Invesco first reported a position in Champions Oncology in Q4 2018 and held it in 8 quarters.
  • Invesco's Champions Oncology position peaked at $493K in Q1 2019.
  • 47 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2020.

Based on Invesco's 13F filing for Q4 2020, filed 16 Feb 2021.